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Abstract
Airway diseases, including cigarette smoke-induced chronic bronchitis, cystic fibrosis, and 
primary ciliary dyskinesia are associated with decreased mucociliary clearance (MCC). However, 
it is not known whether a simple reduction in MCC or concentration-dependent mucus adhesion to 
airway surfaces dominates disease pathogenesis or whether decreasing the concentration of 
secreted mucins may be therapeutic. To address these questions, Scnn1b-Tg mice, which exhibit 
airway mucus dehydration/adhesion, were compared to and crossed with Muc5b- and Muc5ac-
deficient mice. Absence of Muc5b caused a 90% reduction in MCC, whereas Scnn1b-Tg mice 
exhibited an ~50% reduction. However, the degree of MCC reduction did not correlate with 
bronchitic airways pathology, which was observed only in Scnn1b-Tg mice. Ablation of Muc5b 
significantly reduced the extent of mucus plugging in Scnn1b-Tg mice. However, complete 
absence of Muc5b in Scnn1b-Tg mice was associated with increased airway inflammation, 
suggesting that Muc5b is required to maintain immune homeostasis. Loss of Muc5ac had few 
phenotypic consequences in Scnn1b-Tg mice. These data suggest that: (1) mucus 
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hyperconcentration dominates over MCC reduction alone to produce bronchitic airways 
pathology; (2) Muc5b is the dominant contributor to the Scnn1b-Tg phenotype; and (3) therapies 
that limit mucin secretion may reduce plugging, but complete Muc5b removal from airway 
surfaces may be detrimental.
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INTRODUCTION
Secretion and clearance of mucus constitute a conserved mechanism for host protection 
across species. Airway mucus, a heterogeneous mixture of water, mucins, proteins, salts, and 
lipids, is traditionally listed among lung innate defenses due to its ability to trap and mediate 
swift removal of inhaled particles/pathogens by mechanical clearance 1. Effective mucus 
clearance is essential for respiratory health, as illustrated by the poor prognosis of lung 
diseases characterized by airway mucus stasis, e.g., cystic fibrosis (CF), primary ciliary 
dyskinesia (PCD), the bronchitis associated with chronic obstructive pulmonary disease 
(COPD), and bronchiectasis. Regardless of etiology, all of these bronchitic diseases share 
the common hallmarks of abnormal sputum production and an airway pathology reflecting 
epithelial remodeling, mucus accumulation, and inflammation. Increasing efforts have been 
focused on understanding airway mucus biology and, in particular, how the abnormal 
structure and function of mucus may produce disease. A complex picture is emerging, where 
the particular features of diseased mucus might include abnormal concentration 
(“hydration”) 2-4, biogenesis and pH 5-8, macromolecular organization 9,10, and/or functional 
relationships with other components of the host defense, including inflammatory cells 11-13.
The gel-forming mucins MUC5AC and MUC5B, as well as their murine homologs Muc5ac 
and Muc5b, are the principal macromolecular components of airway mucus and dominate its 
biophysical properties14-16. Once secreted into the extracellular space, gel-forming mucins 
are found as mucin/protein complexes with seemingly organized structures 10. MUC5AC 
and MUC5B are different in terms of domain structure, glycosylation, assembly, and 
secretion sites 17, and are thus predicted to have different functions. In humans, cigarette 
smoke-induced chronic bronchitis, CF, and PCD are characterized predominately by 
increases in MUC5B, whereas MUC5AC may be the predominant mucin expressed in 
asthma 3,15,18. Recent reports have identified Muc5b as essential for mucociliary 
clearance 19 and Muc5ac hypersecretion as a major determinant of hyperreactivity to inhaled 
methacoline in allergen-challenged mouse airways20. However, the functional significance 
of these two mucins in the pathogenesis of bronchitic lung diseases remains to be fully 
elucidated.
Defective mucus clearance has been experimentally generated in Scnn1b-transgenic 
(Scnn1b-Tg) mice by airway-targeted overexpression of the epithelial Na+ channel β subunit 
(βENaC, encoded by the Scnn1b gene)21. Expression of the Scnn1b transgene causes airway 
surface dehydration with a consequent increase in mucus concentration, which leads to 
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osmotic compression of cilia, mucus adhesion, and airway obstruction. As noted above, 
airway clearance is also reduced in Muc5b knock-out (Muc5b−/−) mice19, but because these 
two mouse models have been studied independently, the relative contributions of “low” vs 
“high” mucin concentration mechanisms that degrade mucus clearance to the pathogenesis 
of bronchitic lung diseases are unknown.
The overall goal of the present study was to test which specific defect(s) in the mucus 
clearance system, i.e., mucus hyperconcentration/adhesion as observed in the Scnn1b-Tg 
model, or selective reduction in mucus flow, as observed in the Muc5b−/− model, produce 
the pathologic correlate of bronchitis, e.g., airway remodeling, inflammation, and mucus 
accumulation. Further, we investigated which of the major secreted mucins (Muc5ac or 
Muc5b) dominates the muco-obstructive phenotype of Scnn1b-Tg mice and whether genetic 
reductions in mucin concentration might be advantageous. To address these questions, we 
crossed Muc5b−/− mice or Muc5ac−/− mice with Scnn1b-Tg mice and characterized the 
phenotype of the progeny.
RESULTS
Survival and body weights of the Muc5b−/− × Scnn1b-Tg cross progeny
The Muc5b−/− × Scnn1b-Tg cross generated mice of six different genotypes: Muc5b+/+, 
Muc5b+/−, and Muc5b−/− either positive (Scnn1b-Tg) or negative for Scnn1b overexpression 
(See Methods for the mouse nomenclature adopted in the main text and legends). Scnn1b-Tg 
mice exhibited only mild lethality compared to WT littermates (Supplementary Figure 1a), 
regardless of their Muc5b genotype, as expected for mice in a mixed C57BL/6N 22:129/
SV 23 genetic background. At post-natal day (PND) 35 Muc5b−/−Scnn1b-Tg mice exhibited 
a slight reduction in body weight as compared to Muc5b+/+ littermates (Supplementary 
Figure 1b,c), but this finding was not apparent in the progeny of congenic C57 Muc5b−/− × 
Scnn1b-Tg mice (Supplementary Figure 1d-f) .
Mucus hyperconcentration/adhesion is necessary to produce bronchitic lung pathology
To determine whether mucus hyperconcentration/adhesion or reduced mucus flow per se can 
produce bronchitic lung pathology, we first compared Muc5b−/− and Muc5b+/+Scnn1b-Tg 
mice vs. Muc5b+/+ littermates. Histologically, Muc5b−/− mice were indistinguishable from 
Muc5b+/+ littermates (Figure 1a-c). In contrast, Muc5b+/+Scnn1b-Tg mice exhibited a 
severe bronchitic pathology characterized by inflammatory infiltrates, luminal secretions, 
and emphysematous lesions (Figure 1a-c). Airway mucus content was evaluated 
histologically with AB-PAS staining (Figure 1d) and quantified morphometrically as mucus 
volume density (mucus VS, 24) in the airways (epithelial + lumen, Figure 1e) and in the 
epithelia alone (Figure 1f). The mucus content in Muc5b+/+ and Muc5b−/− mice was 
minimal, and mostly confined to the intraepithelial compartment (Figure 1e). In contrast, 
Muc5b+/+Scnn1b-Tg mice exhibited substantial intraluminal mucus accumulation, 
consistent with muco-obstructive lung disease. Secreted mucins were also evaluated by 
western blots of bronchoalveolar lavage (BAL) (Figure 1f,g and Supplementary Figure 2, 
upper panels). Muc5b was absent in Muc5b−/− mice, and the Muc5b BAL content was 
greatly increased in Muc5b+/+Scnn1b-Tg mice, consistent with previous reports25. Parallel 
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quantification of Muc5ac content revealed a modest increase in Muc5b−/− mice as compared 
to Muc5b+/+ mice (~3 fold, p<0.05. Figure 1h), in agreement with previous mRNA and 
immunohistological data19. Muc5b+/+Scnn1b-Tg mice exhibited a significant increase in 
Muc5ac (~ 18 fold vs. Muc5b+/+ mice, Figure 1h), in agreement with previous mRNA 
data 24 and suggesting accumulation of Muc5ac due to poor clearance.
Muc5b deletion ameliorates airway mucus obstruction in Scnn1b-Tg mice
The effect of Muc5b genetic deletion on the phenotype of Scnn1b-Tg mice was evaluated by 
comparing Muc5b−/−Scnn1b-Tg and Muc5b+/−Scnn1b-Tg mice vs. Muc5b+/+Scnn1b-Tg 
littermates. Histologically, all three genotypes exhibited prominent airway inflammation 
(Figure 1a,b) and parenchymal remodeling (Figure 1a,c)
Notably, Muc5b−/−Scnn1b-Tg mice exhibited a significant reduction in intraluminal mucus 
as compared to Muc5b+/+Scnn1b-Tg mice, but secretions adherent to airway surfaces were 
still detected (Figure 1d,e). A genotype-dependent reduction in BAL Muc5b content was 
noted in the Muc5b+/−Scnn1b-Tg and Muc5b−/−Scnn1b-Tg mice (Figure 1g), reflecting 
allelic insufficiency and complete deletion of Muc5b, respectively. Also, there was a 
genotype-dependent increase in BAL Muc5ac content in Muc5b−/−Scnn1b-Tg mice (~ 46 
fold vs. Muc5b+/+ mice and ~ 2.5 fold vs. Muc5b+/+Scnn1b-Tg mice, Figure 1h), likely 
contributing to the residual mucus observed in the airways (Figure 1d).
Muc5ac deletion does not ameliorate airway mucus obstruction in Scnn1b-Tg mice
Initial crosses between Muc5ac−/− and Muc5ac+/−Scnn1b-Tg mice in the C57:129 
background generated mice of four different genotypes (Muc5ac+/−; Muc5ac−/−; 
Muc5ac+/−Scnn1b-Tg; and Muc5ac−/−Scnn1b-Tg) in the expected Mendelian proportions, 
and all exhibited high survival (Supplementary Figure 3a). Analyses performed on the 
progeny of congenic C57BL/6N mice bred to generate all six possible genotypes 
(Muc5ac+/− × Muc5ac+/−Scnn1b-Tg) confirmed that Muc5ac deletion did not significantly 
affect survival (Supplementary Figure 3b)or body mass (Supplementary Figure 3c,d).
Similar to the cross with Muc5b−/− mice, only Scnn1b-Tg mice exhibited bronchitic lung 
pathology when evaluated on H&E stained sections, regardless of Muc5ac genotype (not 
shown). However, in contrast to what was observed for the Muc5b−/− cross, there were no 
differences in AB-PAS positive mucus content, either luminal or epithelial, between 
Muc5ac-deficient or sufficient Scnn1b-Tg mice (Figure 2a-c). These data suggest that 
Muc5ac did not significantly contribute to the intraluminal mucus plugging observed in 
Scnn1b-Tg mice. Quantitation of BAL mucin content (Figure 2d,e and Supplementary 
Figure 2, lower panels) revealed that, contrary to Muc5b−/− mice, Muc5ac−/− mice did not 
exhibit a compensatory increase in Muc5b compared to Muc5ac+/+ mice. Muc5b signal was 
increased in Scnn1b-Tg mice, regardless of Muc5ac genotype. As for Muc5ac BAL content, 
the signal for Muc5ac+/+ and Muc5ac+/− mice was just above background, but an increased 
level of Muc5ac was observed in Muc5ac+/+Scnn1b-Tg mice. Of note, there was a genotype-
dependent reduction of harvested Muc5ac in Muc5ac+/−Scnn1b-Tg and Muc5ac−/−Scnn1b-
Tg mice, reflecting the Muc5ac allelic make-up of the mice.
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Relative contribution of Muc5ac vs. Muc5b to neonatal survival in a model of lethal mucus 
obstruction, the F1 C57:FVB Scnn1b-Tg mouse
As previously reported, the severity of the Scnn1b-Tg muco-obstructive phenotype is 
proportional to airway mucin secretory capacity, which is age- and mouse strain-
dependent22. Specifically, we and others have reported that neonatal mice experience a 
transient increase in Muc5ac and Muc5b secretion during the early postnatal period 
(PND5-10)25,26. The developmentally regulated increase in mucin concentration on airway 
surfaces, coupled to the small caliber of neonatal airways, makes Scnn1b-Tg pups more 
sensitive to the impact of salt and water depletion produced by Scnn1b-Tg overexpression 
and causes fatal tracheal mucus obstruction. We have previously described a variant of 
Scnn1b-Tg mice, F1 C57:FVB Scnn1b-Tg mice22, characterized by extremely high 
postnatal mortality (90%) and higher BAL mucus content as compared to congenic 
C57BL/6N Scnn1b-Tg mice.
Accordingly, we crossed Muc5ac−/−Scnn1b-Tg mice or Muc5b−/−Scnn1b-Tg mice with 
inbred FVB/NJ mice to obtain mice of four different genotypes (Muc+/+, Muc+/−, 
Muc+/+Scnn1b-Tg, Muc+/−Scnn1b-Tg) in a homogeneous F1 C57:FVB genetic background. 
The effect of decreased Muc5ac or Muc5b concentration on survival was evaluated. 
Muc5b+/+ and Muc5b+/− mice had the expected normal, high survival, whereas 
Muc5b+/+Scnn1b-Tg mice were all dead within seven days from birth (Figure 3a). 
Importantly, heterozygosity for Muc5b significantly improved the survival of 
Muc5b+/−Scnn1b-Tg mice (~70% at PND10) as compared to Muc5b+/+Scnn1b-Tg mice 
(~0% at PND10). When similar studies were performed with Muc5ac−/− mice, we observed 
no protection from lethality (Figure 3b) but a modest though significant delay in mortality 
of the Muc5ac+/−Scnn1b-Tg mice as compared to Muc5ac+/+Scnn1b-Tg mice. Collectively, 
these data suggest that Muc5b is the dominant mucin that leads to lethality of Scnn1b-Tg 
mice in the “high mucus producer” FVB background.
Mucociliary transport only partially correlates with the severity of muco-obstructive lung 
disease
A key measurement that has been used to relate airway mucus function to disease has been 
the rate of mucociliary clearance (MCC)2. Accordingly, we compared the relative rates of 
mucus transport in the two models of defective airway clearance, i.e., Scnn1b-Tg and 
Muc5b−/− mice. Furthermore, to test whether a reduction in mucin concentration in the lungs 
of Scnn1b-Tg mice produced by absence of Muc5b might rescue mucus transport, we also 
measured MCC in Muc5b−/−Scnn1b-Tg.
As shown in Figure 4, Muc5b+/+ mouse lungs cleared ~75% of the tracer particles within 15 
minutes after instillation. In contrast, there was almost a complete loss of MCC in Muc5b−/− 
mice, as previously reported19. Also similar to previous reports21, a ~50% reduction in MCC 
was observed in Muc5b+/+Scnn1b-Tg mice. Notably, deletion of Muc5b in Scnn1b-Tg mice 
did not rescue mucus transport, but rather caused a reduction in MCC towards the levels 
exhibited by Muc5b−/− mice.
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Deletion of Muc5b or Muc5ac does not affect bacterial burden or ameliorate airway 
inflammation in Scnn1b-Tg mice
Because both Scnn1b-Tg and Muc5b−/− mice have increased susceptibility to spontaneous 
and experimentally induced airway bacterial infection19,21,27, we tested whether the 
combination of the two genotypes would produce an additive phenotype. As effects of 
Muc5ac deletion on intestinal pathogen clearance have also been reported 28, microbiology 
experiments were also performed for the Muc5ac−/− × Scnn1b-Tg cross.
At PND5 7, Muc5b−/− mice exhibited an incidence of infection of ~50% compared to 0% in 
Muc5b+/+ mice, with a bacterial burden of ~1.5 Log CFU/mouse (Figure 5a). In contrast, 
virtually all neonatal Scnn1b-Tg mice were infected with a bacterial burden of ~3 Log CFU/
mouse, and this infection was not affected by the Muc5b genotype. At PND35, none of the 
Muc5b−/− mice were infected, and sporadic infections were detected in Scnn1b-Tg mice 
(Figure 5b), in agreement with previous reports27. Similar to neonatal Scnn1b-Tg mice, 
there was no appreciable difference in bacterial burden due to Muc5b genotype in adult WT 
or Scnn1b-Tg mice. A similar picture emerged from the microbiological analysis of BAL 
samples harvested from mice derived from Muc5ac−/− × Scnn1b-Tg crosses at PND5 7 
(Supplementary Figure 4), with the notable exception that Muc5ac−/− neonatal mice did 
not exhibit the incidence of spontaneous bacterial infection observed in neonatal Muc5b−/− 
mice.
To test whether genetic ablation of Muc5ac or Muc5b affected the airway inflammatory 
profile of Scnn1b-Tg mice, we characterize BAL cells in neonatal (PND5 7) and adult 
(PND35) mice. Neutrophil counts were elevated in both Muc5b−/− and Muc5b+/+Scnn1b-Tg 
neonatal mice as compared to Muc5b+/+ littermates (Figure 5c), in agreement with the 
presence of bacteria. Rather than rescuing this phenotype, Muc5b deletion caused a trend 
towards worsening of the neutrophil infiltration in Scnn1b-Tg mice. In adult mice, there was 
a modest but significant increase in neutrophil count in Muc5b−/− mice, whereas the 
neutrophil infiltrate was much greater in Muc5b+/+Scnn1b-Tg mice (Figure 5d). However, 
the airway neutrophilia typical of adult Scnn1b-Tg mice was not ameliorated by either 
partial (Muc5b+/−Scnn1b-Tg mice) or total (Muc5b−/−Scnn1b-Tg mice) ablation of Muc5b. 
Rather, a gene-dosage dependent trend towards worsening of airway neutrophilia was 
observed (Muc5b+/+ > Muc5b+/− > Muc5b−/−). Muc5b deletion alone was not associated 
with significant changes in macrophage numbers either in neonatal (Supplementary Figure 
5a) or adult WT mice (Supplementary Figure 5b). Neonatal Scnn1b-Tg mice exhibited a 
modest increase in BAL macrophages as compared to WT littermates, regardless of Muc5b 
genotype, but this increase was normalized in adult mice with only the Muc5b−/−Scnn1b-Tg 
mice exhibiting a significant difference versus WT littermates.
As a parallel readout of airway inflammation, we evaluated the BAL chemokine and 
cytokine profiles in adult mice. The neutrophil chemoattractant chemokines (C-X-C motif) 
ligand 1 (CXCL1 or KC) and lipopolysaccharide-induced CXC chemokine (LIX) were 
significantly elevated in Scnn1b-Tg mice as compared to both WT and Muc5b−/− mice 
(Figure 6a,b). Genetic deletion of Muc5b did not alter the levels of these inflammatory 
markers in Scnn1b-Tg mice. Although it did not reach significance, macrophage 
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inflammatory protein (MIP)-2 was elevated in all Scnn1b-Tg samples, regardless of Muc5b 
genotype (Supplementary Figure 5c), whereas IL-6 and TNFα were below the lower limit 
of detection in all samples (data not shown).
As for the progeny of the Muc5ac−/− × Scnn1b-Tg cross, partial or total Muc5ac deletion did 
not cause neutrophilia or altered BAL macrophage counts in either neonatal 
(Supplementary Figure 6a,c) or adult (Supplementary Figure 6b,d) WT mice. Of note, 
Muc5ac deletion did not rescue the BAL neutrophilia in either neonatal or adult Scnn1b-Tg 
mice (Supplementary Figure 6a,b), and only a slight increase in BAL macrophage 
numbers was detected in neonatal Muc5ac−/−Scnn1b-Tg mice as compared to WT 
littermates (Supplementary Figure 6d).
Deletion of Muc5b, but not Muc5ac, worsens the incidence of bronchus-associated 
lymphoid tissue (BALT) in Scnn1b-Tg mice
Histopathological analysis of lung sections stained with hematoxylin and eosin (H&E, 
Figure 7a) using a semi-quantitative score25 (Supplementary Figure 7a,b) and quantitative 
morphometry (Figure 7b) indicated that BALT was absent in PND35 WT mice, regardless 
of Muc5ac or Muc5b genotype, whereas low level accumulation of this ectopic lymphoid 
tissue could be detected in mucin-sufficient Scnn1b-Tg mice at this time point. Of note, 
Muc5b deletion significantly increased the incidence of BALT in Scnn1b-Tg mice, whereas 
Muc5ac deletion did not modify this phenotype. This increase in BALT was not reflected in 
the total number of BAL lymphocytes, which was elevated in Scnn1b-Tg mice regardless of 
Muc5b genotype (Figure 7c). Both B and T cells were present in these lymphoid nodules 
(Figure 7d), and their rather loose organization suggested recently formed, inducible 
BALT29.
We sought to determine if there was a correlation between incidence of BALT and 
immunoglobulin concentrations in BAL harvested from the progeny of the Muc5b−/− × 
Scnn1b-Tg cross. A striking increase in IgA was observed in all Scnn1b-Tg samples, 
regardless of Muc5b genotype (Figure 8a). Except for an increase in IgG1 in 
Muc5b−/−Scnn1b-Tg mice (Figure 8b), no systematic differences were observed for other 
IgG subtypes or IgM as a function of Muc5b genotype (Supplementary Figure 8a-d). 
Longitudinal studies comparing Scnn1b-Tg and WT littermates showed that IgA levels are 
increased in the BAL of Scnn1b-Tg mice beginning at PND10 (Supplementary Figure 8e). 
Since it has been proposed that IgA binding to mucus through the polymeric Ig receptor 
secretory component (SC) is essential for IgA function in the lung30, we tested whether 
selective deletion of Muc5b or Muc5ac would modify the localization of SC in WT or 
Scnn1b-Tg mice. As shown in Figure 8c, SC was exclusively localized to the surface 
epithelium in both Muc5b+/+ and Muc5b−/− mice (as well as Muc5ac−/− mice, not shown), 
whereas it was abundant in the luminal mucous secretions of Scnn1b-Tg mice, and its 
localization was not altered in the absence of either Muc5ac or Muc5b.
DISCUSSION
Many aspects of lung mucus biology have become better defined in recent years. For 
example, it appears that Muc5b, not Muc5ac, is the dominant mucin that confers to the 
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mucus layer the properties required for transport in the healthy lung 19. Moreover, the 
dominant role of mucins in producing the biophysical properties governing mucus flow in 
health versus reduced/no flow in disease has also become better appreciated. Notably, a 
novel paradigm posits that healthy airway surfaces are populated by two mucus hydrogel 
layers, one comprised of the mobile layer (where Muc5b is dominant) and the other 
comprised of the periciliary layer, enriched in tethered mucins including Muc1, Muc4, and 
Muc16 4. The identification of this two-gel topology for the airway surface 9 is key to 
quantify biophysical variables related to the distribution of water between the two hydrogels, 
which ultimately determines the efficiency of mucus transport 4. Of particular relevance for 
this study is the notion that mucus clearance is inversely proportional to its concentration, a 
concept recently translated to the clinic 2.
It is clear that mucins play an important role in the pathogenesis of bronchitic lung diseases, 
which are clinically characterized by increased sputum production over defined periods of 
time, and pathologically associated with airway epithelial remodeling, including goblet cell 
metaplasia, inflammation and mucus plugging. Despite the likely importance of mucus in 
the pathogenesis of these diseases, it is not clear whether abnormal qualitative or quantitative 
properties of mucus produce disease. Specifically, it is not clear whether the simple absence 
of mucus clearance, abnormal ratios of MUC5AC to MUC5B, or abnormal mucus 
concentration are required features to initiate pathology. Heretofore it has been difficult to 
experimentally separate the two different pathologic mechanisms, e.g., absence of transport 
versus presence of hyperconcentration, which is key to address this question.
Recently, the opportunity to study the role of mucins subtypes, mucus concentration, and 
mucus transport in the pathogenesis of bronchitic lung disease has been afforded by the 
generation of mouse models that produced different perturbations of airway mucus biology. 
Specifically, the availability of Muc5b−/− mice, which exhibit very slow airway mucus 
transport19, and Scnn1b-Tg mice, which exhibit airway mucus hyperconcentration and 
adhesion to airway surfaces21, has provided the opportunity to assess the relative roles and 
possible interactions of these dysfunctions in a common cohort.
In the studies reported here, the progenies from the mucin deficient × Scnn1b-Tg mice 
crosses were compared utilizing metrics of bronchitic disease severity. Mucin-sufficient 
Scnn1b-Tg mice exhibited a relatively severe bronchitic phenotype, including: 1) increased 
airway mucus burden (Figure 1 and 2); 2) highly penetrant spontaneous bacterial infection 
(Figure 5); 3) significant inflammatory infiltrates (Figure 5); 4) epithelial/parenchymal 
remodeling (Figure 1 and 7); and 5) increased in pro-inflammatory cytokines (Figure 6) 
consistent with previous reports 24,25,27. Novel to this study, we observed another index of 
increased immune responses, i.e., high concentrations of IgA in Scnn1b-Tg BALF (Figure 
7e). In contrast, Muc5b−/− mice exhibited a milder disease, with a lesser incidence of 
bacterial infection, fewer BAL neutrophils, lower levels of pro-inflammatory cytokines and 
IgA, and importantly no histological evidence of airway epithelial remodeling or 
emphysema. In parallel, no evidence of spontaneous lung disease was observed in 
Muc5ac−/− mice, consistent with previous reports20.
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Interestingly, the severity of the obstructive and inflammatory airway phenotype did not 
simply reflect the rates of airway mucus clearance. As shown in Figure 4, airway 
mucociliary clearance in Muc5b−/− mice was indeed lower than in Scnn1b-Tg mice, despite 
the milder phenotype of the former. Accordingly, we speculate that it is not a reduction in 
the absolute rate of mucus clearance that dominates the pathogenesis of bronchitis, but it is 
the presence of hyperconcentrated mucus adherent to the airway surfaces, as evident in 
Scnn1b-Tg mice (Figures 1, 2 and 7). This interpretation is consistent with findings in other 
mouse models that exhibit defective mucus transport but lack a mucus-adhesive component, 
e.g., models of primary ciliary dyskinesia (PCD), which also exhibit a mild lower airway 
phenotype 3133.
Crossing the Muc5b−/− and Muc5ac−/− mice with Scnn1b-Tg mice also offered the 
opportunity to query the role of the two major secreted mucins in the development of the 
Scnn1b-Tg phenotype. Muc5ac-deficient Scnn1b-Tg mice exhibited little/no change as 
compared to Muc5ac-sufficient Scnn1b-Tg mice (Figure 2). In contrast, the magnitude of 
mucus obstruction in Scnn1b-Tg mice was significantly reduced in the absence of Muc5b, as 
evaluated both morphometrically and by BAL western blot (Figure 1e,f,g,h), consistent with 
the notion that Muc5b is the major secreted mucin in mouse airways 19,26,34. Despite the 
reduction in mucus burden, areas of mucus adhesion persisted histologically (Figure 1d,e). 
These plugs likely contained Muc5ac, consistent with the significant accumulation of 
Muc5ac in the BAL fluid of Muc5b−/−Scnn1b-Tg mice (Figure 1h).
The availability of a mouse strain that exhibits a lethal muco-obstructive phenotype, i.e., F1 
C57:FVB Scnn1b-Tg mice, allowed us to investigate whether decreased levels of Muc5b or 
Muc5ac could rescue survival. Heterozygosity for Muc5b, but not Muc5ac, was sufficient to 
significantly rescue the survival of F1 C57:FVB Scnn1b-Tg mice (Figure 3). Based on the 
data that Muc5b+/−Scnn1b-Tg mice exhibit ~50% the levels of BAL Muc5b as compared to 
Muc5b+/+Scnn1b-Tg mice (Figure 1g), it is likely that the reduction of Muc5b was 
responsible for the large increase in survival. In contrast, Muc5ac+/−Scnn1b-Tg mice 
exhibited a modest increase in time to death as compared to Muc5ac+/+Scnn1b-Tg mice, 
suggesting that a Th2- or developmentally-driven increase in Muc5ac might be detrimental 
to survival early in life.
Importantly, inflammation in Muc5b−/−Scnn1b-Tg mice was not reduced proportionately to 
mucus obstruction. Instead, there was an overall increase in the severity of pulmonary 
inflammation as indexed by increased number of BAL neutrophils and BALT (Figures 5 
and 7), These findings suggest that other factors in addition to mucus obstruction can lead to 
pulmonary inflammation. Perhaps the simplest explanation for the increased inflammatory 
phenotype in Muc5b−/−Scnn1b-Tg mice is that reduction of secreted Muc5b did not rescue 
the defective airway clearance of Scnn1b-Tg mice but, rather, further reduced mucus 
clearance to the levels of Muc5b−/− mice (Figure 4). This reduction could promote further 
adhesion of other mucus components, possibly Muc5ac, to airway surfaces as well as 
prolong the residence time of pro-inflammatory particles or debris initiating a predictable 
inflammatory response. Alternatively, it has been reported that mucins may “communicate” 
with inflammatory cells, including macrophages and dendritic cells 12,13,3537, and perhaps 
the absence of Muc5b contributed per se to an exaggerated inflammatory response in 
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Muc5b−/−Scnn1b-Tg mice. Finally, gel-forming mucins, and particularly Muc5b, are 
associated with a network of proteins forming macromolecular complexes, known as “mucin 
interactomes”, which are thought to be involved in maintaining airway immune homeostasis 
through their anti-microbial/anti-inflammatory/anti-oxidant functions38,39. Derangement of 
this network may have adverse effects in controlling airway inflammation.
Another unexpected finding of this study was that Muc5b deletion did not affect bacterial 
burden in Scnn1b-Tg mice (Figure 5a,b) despite a reduction in mucus plugs. A possible 
interpretation is that while Muc5b deletion decreased mucus plugging, it also reduced 
clearance of inhaled bacteria (as indicated by the presence of bacteria in 50% of the neonatal 
Muc5b−/− mice), offsetting the beneficial effect of reduced plugging. We can also speculate 
that the composition of neonatal mucus, enriched in Muc5ac as compared to adult mice (26 
and A. Livraghi-Butrico, unpublished data), might also contribute to increased, Muc5b-
independent trapping of bacteria.
As noted above, we found that IgA BAL levels were elevated in Scnn1b-Tg mice, suggesting 
that mucus hyperconcentration/adhesion stimulates local IgA production and secretion. IgA 
levels were elevated independently of Muc5b genotype, suggesting that the residual degree 
of mucus obstruction was sufficient to stimulate IgA synthesis and secretion. Importantly, 
previous reports have shown that SC-mediated binding of IgA to mucus is required for its 
function30. Our immunohistological data (Figure 8c) suggest that SC binding to the mucus 
is not Muc5ac- or Muc5b-dependent. However, we can not rule out the possibility that the 
overall decrease in intraluminal Muc5b in Muc5b−/−Scnn1b-Tg mice removed an essential 
“scaffold” for secreted IgA, impairing immune exclusion 40 and promoting inflammation.
In conclusion, mucus biology in the normal and diseased lung is complex and likely involves 
not only the biophysical contributions of mucins to mucus transport but also interactions 
with host immune cells and defense proteins. Our data suggest that mucus 
hyperconcentration/adhesion rather than the loss of mucus flow dominates the 
pathophysiology of bronchitic lung diseases, and, consequently, these diseases may be 
characterized as “muco-obstructive” lung diseases. So, what is pathogenic in static/adherent 
mucus? Mucus adhesion certainly blocks airflow, and it is in part responsible for the reduced 
airflow observed in muco-obstructive lung diseases. Adherent mucus is also the site of most 
bacterial airways infections, including those causing exacerbations in CF and COPD, and, 
even when “sterile”, it appears to be a pro-inflammatory DAMP27. Moreover, mucus 
plugging induces local, epithelia hypoxia24, which is an increasingly recognized feature of 
the CB syndrome41, important for both inflammatory responses and anaerobic infection. 
Notably, therapies designed to clear mucus from airway surfaces are predicted to be 
therapeutic for these conditions. The simplest therapies involve the “rehydration” of mucus 
so that its concentration is restored to levels compatible with transport. It is also likely that 
therapies designed to reduce mucin secretion, and thus reduce concentrations, may also be 
useful. However, our data suggest that a complete loss of secreted mucins, especially 
MUC5B, may worsen pathology, so a more moderate titration might be needed 
therapeutically.
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METHODS
Animals
Animals were maintained and studied under protocols approved by the University of North 
Carolina Institutional Animal Care and Use Committee, according to the principles outlined 
by the Animal Welfare and the National Institutes of Health guidelines. Mice were housed in 
individually ventilated micro-isolator cages in a specific pathogen-free facility at the 
University of North Carolina at Chapel Hill, on a 12-hour day/night cycle. Mice were fed a 
regular chow diet and given water ad libitum.
Muc5ac−/− 20 and Muc5b−/− 19 mice were obtained from the Laboratory of Dr. Christopher 
Evans as C57BL/6J:129/Sv line. Congenic C57BL/6N Scnn1b-Tg mice and wild-type (WT) 
littermates were maintained as a hemizygous as described 22 and referred to as WT (i.e., 
Scnn1b-Tg− or Scnn1b-Tg negative) or Scnn1b-Tg (i.e., Scnn1b-Tg+ or Scnn1b-Tg 
positive). Mucin-deficient Scnn1b-Tg mice and appropriate littermate controls were 
generated by sequential breeding of congenic C57BL/6N hemizygous Scnn1b-Tg mice with 
Muc5ac−/− or Muc5b−/− mice, using a breeding strategy previously described 25. For clarity, 
genotypes of the progenies are indicated in the main text and figure legends as follows: 
Muc5ac+/+/Scnn1b-Tg− = Muc5ac+/+; Muc5ac+/−/Scnn1b-Tg− = Muc5ac+/−; Muc5a−/−/
Scnn1b-Tg− = Muc5ac−/−; Muc5ac+/+/Scnn1b-Tg+ = Muc5ac+/+Scnn1b-Tg; Muc5ac+/−/
Scnn1b-Tg+ = Muc5ac+/−Scnn1b-Tg; Muc5a−/−;Scnn1b-Tg+ = Muc5ac−/−Scnn1b-Tg; and 
similarly for the Muc5b−/− × Scnn1b-Tg cross. Congenic C57BL/6N Muc5ac−/− and 
Muc5b−/− mice were generated by crossing heterozygous mice to inbred C57BL/6N mice 
(Taconic, Hudson, NY) for more than 12 generations. Mixed-strain or congenic mice were 
used as described in the text. At post-natal day (PND) 1 or 2, pups were toe clipped for 
identification and genotyping, as previously described 21. Mice studied were littermates, 
age-matched and of both sexes. Congenic FVB/NJ mice were purchased from The Jackson 
Laboratory (Bar Harbor, Maine).
Bronchoalveolar lavage (BAL), cell counts, analyses of soluble contents and bacteriology
BAL was performed in neonatal and adult mice as previously described 25. For microbiology 
studies, BAL was performed aseptically and colony forming units (CFUs) enumerated were 
enumerated in serially plated dilutions [plated onto Columbia anaerobe sheep blood agar 
(Becton Dickinson, NJ) and incubated in a candle jar to facilitate the growth of 
microaerophilic bacteria at 37°C for 24 hours], as previously described 27. Mouse TNFα, 
KC, MIP-2, LIX, IL-6, IgG1, IgG2a, IgG2b, IgG3, IgA, and IgM were measured in cell-free 
BAL using a Luminex-based assay (EMD Millipore, Billerica, MA), according to the 
manufacturer's instructions.
Lung histology
Lungs were immersion-fixed in 10% neutral-buffered formalin (NBF) to prevent dislodging 
of airway luminal contents. Paraffin-embedded sections were stained with hematoxylin and 
eosin (H&E) and Alcian Blue-Periodic Acid Schiff staining (AB-PAS), and lung pathology 
graded as previously described using a semi-quantitative histology score 25 or 
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morphometry24. Tissue blocks received a numerical code at time of embedding and scoring 
was performed by an investigator blinded to specimen genotype.
Agarose gel mucin western blot
Secreted mucin quantification was carried out using a slight modification of the protocol 
described in 25. BAL samples were solubilized by addition of urea to reach a 6M 
concentration. Samples were reduced with 10 mM dithiothreithol for 90 min at 37°C and 
alkylated with 25 mM iodoacetamide for 30 min at room temperature (RT) in the dark. 
Equal volumes of reduced samples (40 μl) were run on 1% agarose gel at 80 V for 90 min. 
Gels were vacuum-blotted onto nitrocellulose membranes with 4x sodium citrate buffer 
(SSC) for 2 hours, blocked with Odyssey blocking buffer (OBB, Li-COR Biosciences, 
Lincoln, NE), and probed with rabbit polyclonal antibodies against Muc5b (UNC223, 
1:2000 in OBB34) or Muc5ac (UNC294, 1:1000 in OBB+0.1% Tween-20, 42). The 
secondary antibody was IRDye 680LT donkey anti-rabbit IgG (Li-COR Biosciences), 
diluted 1:15,000 in OBB. Detection and densitometry were performed using the Odyssey 
Infrared Imaging System (LI-COR Biosciences).
Mucociliary clearance (MCC) assay
PND35 mice were anesthetized with 2-3 % isoflurane and a small incision was made 
through the tracheal ventral wall. Using a fine-bore cannula, 200 nl of PBS containing a 
known number of fluorescent microspheres (3 μm Molecular Probes FluoSpheres, Nile Red, 
Invitrogen Corp.) was deposited near the tracheal bifurcation. After the cannula was 
removed and the tracheostomy closed, the anesthetized mouse was allowed to breath 
spontaneously for 15 minutes. After this period, the mouse was euthanized, the lungs and 
trachea (up to the larynx) were removed and solubilized in KOH, and the beads left in the 
tissue were counted. MCC was determined as % of delivered beads that were cleared.
Immunofluorescence analysis of BALT
Lungs were inflated with a 1:1 mixture of OCT:PBS, embedded in 100% OCT and 
sectioned. Slides were air dried, fixed in ice cold 100% acetone for 5 min, and washed in 
PBS. Blocking was performed in 5% normal goat serum (NGS, Jackson ImmunoResearch 
Laboratories Inc., West Grove, PA), 1:50 Fc Block (BD Biosciences, rat anti-mouse CD16/
CD22 clone 2.4G2), 0.1% Tween-20, and 0.1% Triton-X in PBS, for 30 min at RT. Primary 
antibodies and isotype controls [goat anti-mouse CD3-ε (M-20) Santa Cruz and goat IgG 
Jackson ImmunoResearch 0.2 mg/ml, dil. 1:100; rat anti-mouse CD45R/B220 and rat IgG2a, 
κ both from BD Biosciences, dil. 1:50] were diluted in PBS + 0.1% Tween-20 + 0.1% 
Triton-X (PBS-TT) and incubated over night at 4°C. Sections were washed in PBS + 0.1% 
Tween-20 (PBST) and secondary antibodies (donkey anti-goat AlexaFluor 633 and donkey 
anti-rat AlexaFluor 594, Jackson ImmunoResearch, both at 1:200 dilution in PBSTT) were 
applied for 60 min at RT in the dark. After washing in PBST, slides were mounted with 
Vectashield Soft Mount media (Vector laboratories) containing DAPI for nuclear staining, 
and imaged by confocal microscopy, using a Leica SP2 microscope with an Apochromat 
40x/1.25 NA oil immersion lens.
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Immunohistochemical localization of SC
Lungs were immersion fixed in 10% NBF for 24 hours. Paraffin embedded sections were 
incubated at 65°C for 2-4 hours, and deparaffinized with xylene (2 changes × 5’) and graded 
ethanol (100% 2 × 5’, 95% 1 × 5’, 70% 1 × 5’). After rehydration, antigen retrieval was 
performed by boiling the slides in 0.1M sodium citrate pH 6.00 (3 cycles with microwave 
settings: 100% power for 6.5 min, 60% for 6 min, and 60% for 6 min, refilling the Coplin 
jars with deionized water after each cycle). After cooling and rinsing with dH2O, quenching 
of endogenous peroxidase was performed with 0.5% H2O2 in methanol for 15 min, slides 
were washed in PBS, and blocked with 5% normal donkey serum (NDS), 1:50 Fc block in 
PBS-T, for 1 hr at RT. Primary antibodies and isotype control (goat anti-mouse pIgR R&D 
Systems AF2800 and goat IgG Jackson ImmunoResearch 0.2 mg/ml) were diluted in 5% 
NDS in PBST and incubated over night at 4°C. Sections were washed in PBS and secondary 
antibody (biotinylated donkey anti-goat IgG, Jackson ImmunoResearch, at 1:200 dilution in 
5% NDS in PBST) was applied for 30 min at RT. After washing in PBST, slides were 
incubated with avidin-peroxidase complex according to the manufacturer instruction 
(Vectastain kit, Vector laboratories), washed, incubated with the chromogenic substrate 
(Immpact Novared, Vector laboratories) and counterstained with Mayer hematoxylin. 
Coverslipped slides were imaged by transmitted light microscopy, using an Olympus BX60 
microscope with an UPlanFLN 40x/0.75 NA lens.
Statistics
Data are shown as means ± SEM, with the number of mice (n). Survival curves were 
compared using Kaplan-Meier followed by Log-rank analysis (Mantel-Cox) with Bonferroni 
correction for multiple comparisons. ANOVA followed by Tukey's post-hoc test for multiple 
comparisons was used to determine significant differences among groups for body weight, 
BAL cell and CFUs counts, MCC, BAL mucins content, BALF cytokines and 
immunoglobulin content, histology scores, and morphometric analyses. p<0.05 was 
considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Mucus hyperconcentration/adhesion is necessary to produce bronchitic lung pathology, 
but Muc5b deletion ameliorates airway mucus obstruction in Scnn1b-Tg mice
(a) Representative photomicrographs of airway lumens cut in cross section proximal to the 
hilum from PND35 mice of the indicated genotypes, stained with H&E illustrating airway 
mucus obstruction and inflammatory infiltrates characteristic of bronchitic lung pathology in 
Scnn1b-Tg mice. (b-c) Semi-quantitative histology scores for airway inflammation (b) and 
air space enlargement (c) in PND35 mice from the Muc5b−/− × Scnn1b-Tg cross in the 
C57:129 genetic background. n= 6-9 mice/genotype. ANOVA * p<0.05 vs. Muc5b+/+ mice. 
(d) Equivalent sections as in (a) stained with AB-PAS for mucopolysaccharides, illustrating 
significant amelioration of mucus obstruction in Muc5b−/−Scnn1b-Tg vs. Muc5b+/+Scnn1b-
Tg mice. Scale bar 0.1 mm. (e-f) Morphometric analysis of total (epithelial+luminal, e) and 
epithelial (f) airway mucus volume density (Vs) in PND35 mice (C57:129 genetic 
background). n= 6-9 mice/genotype. ANOVA * p<0.05 vs. Muc5b+/+ mice, # p<0.05 vs. 
Muc5b+/+Scnn1b-Tg mice. (g-h) Densitometric analysis of mucin agarose western blots of 
BAL from the progeny of the Muc5b−/− × Scnn1b-Tg cross in the C57 congenic 
background, at PND35. Blots were probed with anti-Muc5b (g) or anti-Muc5ac (h) 
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antibodies. n=6 mice/genotype. ANOVA * p<0.05 vs. Muc5b+/+ mice, # p<0.05 vs. 
Muc5b+/+Scnn1b-Tg mice.
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Figure 2. Muc5ac deletion does not ameliorate airway mucus obstruction in Scnn1b-Tg mice
(a) Representative photomicrographs of proximal left lobe main stem bronchus from PND35 
mice of the indicated genotypes, stained with AB-PAS for mucopolysaccharides, illustrating 
no changes in mucus obstruction in Muc5ac−/−Scnn1b-Tg vs. Muc5ac+/−Scnn1b-Tg mice. 
Scale bar 0.1 mm. (b-c) Morphometric analysis of total (epithelial+luminal, b) and epithelial 
(c) airway mucus volume density (Vs) in PND35 mice (C57:129 genetic background). n= 
6-11 mice/genotype. ANOVA * p<0.05 vs. Muc5ac+/+ mice. (d-e) Densitometric analysis of 
mucin agarose western blots of BAL from the progeny of the Muc5ac−/− × Scnn1b-Tg cross 
in the C57 congenic background, at PND35. Blots were probed with anti-Muc5b (d) or anti-
Muc5ac (e) antibodies. n= 6 mice/genotype. ANOVA * p<0.05 vs. Muc5ac+/+ mice, # 
p<0.05 vs. Muc5ac+/+Scnn1b-Tg mice.
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Figure 3. Relative contribution of Muc5ac vs. Muc5b to neonatal survival in a model of lethal 
mucus obstruction, the F1 C57:FVB/NJ Scnn1b-Tg mice
Survival curves for the progeny of the Muc5b−/−Scnn1b-Tg mice (a) or Muc5ac−/−Scnn1b-
Tg mice (b) crossed with inbred FVB/NJ mice. Muc5b heterozygosity improved overall 
survival of F1 C57:FVB Scnn1b-Tg mice, whereas Muc5ac heterozygosity only resulted in 
delayed time of death (median survival PND 9 vs. PND 5 for Muc5ac+/−Scnn1b-Tg mice vs. 
Muc5ac+/+Scnn1b-Tg mice, respectively). * p<0.05 vs. Muc+/+ littermates, # p<0.05 vs. 
Muc+/+Scnn1b-Tg littermates.
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Figure 4. Mucociliary transport only partially correlates with the severity of muco-obstructive 
lung disease
Mucociliary clearance measurements in selected genotypes from the progeny of the 
Muc5b−/− × Scnn1b-Tg cross in the C57 congenic background, at PND35. n=6-14 mice/
genotype. ANOVA * p<0.05 vs. Muc5b+/+ mice, # p<0.05 vs. Muc5b+/+Scnn1b-Tg mice.
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Figure 5. Deletion of Muc5b or Muc5ac does not affect bacterial burden or ameliorate airway 
inflammation in Scnn1b-Tg mice
(a,b) Quantification of colony forming units (CFU) in BAL samples from the progeny of the 
Muc5b−/− × Scnn1b-Tg cross in the C57:129 genetic background, at PND5-7 (a) or PND35 
(b). (Log10+1)-transformed data. n= 8-24 mice/genotype (a) and n=5-8 mice/genotype (b). 
ANOVA * p<0.05 vs. Muc5b+/+ mice. (c-d) BAL neutrophil counts for the progeny of the 
Muc5b−/− × Scnn1b-Tg cross in the C57:129 genetic background, at PND5-7 (c) or PND35 
(d) n= 7-24 mice/genotype (c) and n=11-15 mice/genotype (d). ANOVA * p<0.05 vs. 
Muc5b+/+ mice.
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Figure 6. Deletion of Muc5b does not alter the BAL chemokine and cytokine profile in Scnn1b-
Tg mice
KC (a) and LIX (b) levels in cell-free BAL from the progeny of the Muc5b−/− × Scnn1b-Tg 
cross in the C57:129 genetic background at PND35. The dotted line represents the assay 
lower detection limit (LOD). n= 5-8 mice/genotype. ANOVA * p<0.05 vs. Muc5b+/+ mice.
Livraghi-Butrico et al. Page 23
Mucosal Immunol. Author manuscript; available in PMC 2017 March 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. Deletion of Muc5b, but not Muc5ac, worsens the incidence of bronchus-associated 
lymphoid tissue (BALT) in Scnn1b-Tg mice
(a) Representative micrographs of proximal left lobe main stem bronchus from PND35 
mice, stained with H&E, illustrating typical histopathology for the indicated genotypes. 
Scale bar 0.2 mm. Airway mucus obstruction was evident in Muc5b+/+Scnn1b-Tg mice and 
Muc5ac−/−Scnn1b-Tg mice (asterisks), but it was less severe in Muc5b−/−Scnn1b-Tg mice. 
However, Muc5b−/−Scnn1b-Tg mice presented with a higher incidence of BALT (arrow and 
high magnification inset, scale bar 20 μm). (b) Morphometric analysis of BALT in PND35 
mice (C57:129 genetic background). n= 6-9 mice/genotype. ANOVA * p<0.05 vs. Muc5b+/+ 
mice. (c) BAL lymphocyte counts for the progeny of the Muc5b−/− × Scnn1b-Tg cross in the 
C57:129 genetic background, at PND35. n= 11-15 mice/genotype. ANOVA * p<0.05 vs. 
Muc5b+/+ mice. (d) Representative confocal images of BALT immunostained with B and T 
cells specific markers (B220 in red and CD3 in green, respectively), and relevant isotype 
negative controls (rat IgG2a,k and goat IgG, respectively). Nuclei are stained in blue 
(DAPI). Differential interference contrast (DIC) image is provided to illustrate the typical 
localization of BALT in the airway submucosal compartment.
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Figure 8. Airway mucus hyperconcentration/adhesion stimulates IgA secretion
(a,b) IgA (a) and IgG1 (b) levels in cell-free BAL from the progeny of the Muc5b−/− × 
Scnn1b-Tg cross in the C57:129 genetic background at PND35. The dotted line represents 
the assay lower detection limit (LOD). n= 5-8 mice/genotype. ANOVA * p<0.05 vs. 
Muc5b+/+ mice. (c) Immunohistochemical localization of the polymeric Ig receptor 
secretory component (SC) in the main stem bronchus of mice for the indicated genotypes. A 
serial section to the one used for Muc5b+/+Scnn1b-Tg SC stain is shown as negative IgG 
control (IgG control).
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